Most detox centers treat withdrawal symptoms: shaking, nausea, insomnia, pain. That is necessary work — but it is not the complete picture. What very few facilities address is what substances have done to your endocrine system, and why that matters for how you feel months after detox ends. Pathways Recovery Center runs a comprehensive blood panel on every patient at admission. That panel includes hormone markers. Where clinically appropriate, we discuss hormone optimization and HRT integration as part of your care. This page explains why that matters, what we test, and what it means for your recovery.
How Substance Use Disrupts the Endocrine System
Opioids and Methadone — Opioid-Induced Androgen Deficiency (OPIAD). Chronic opioid use suppresses the hypothalamic-pituitary-gonadal (HPG) axis. Opioids inhibit GnRH release from the hypothalamus, which reduces LH and FSH from the pituitary, which in turn suppresses testosterone production in men and estrogen/progesterone production in women. The result in men: total testosterone levels that routinely fall below 200 ng/dL — the equivalent of a 70-year-old man’s testosterone profile — despite a patient being in their 30s or 40s. OPIAD is documented in peer-reviewed literature (PMC, NIH) and is measurable on a standard blood panel. Men with OPIAD in recovery experience fatigue, depression, low libido, muscle loss, and cognitive fog — symptoms often misattributed to PAWS or depression. The underlying cause is hormonal, not psychological.
Alcohol — Estrogen Elevation and Progesterone Disruption. Alcohol disrupts hepatic metabolism of estrogens. The liver normally processes and clears estrogens from circulation; alcohol impairs this function. In men, this produces elevated estrogen levels, gynecomastia (breast tissue development), testicular atrophy, and reduced testosterone. In women, alcohol disrupts progesterone production and can accelerate the onset of perimenopause in chronic heavy drinkers. These are measurable, documented hormonal changes — not abstract concepts.
Methamphetamine and Stimulants — Cortisol and Adrenal Dysregulation. Chronic stimulant use drives the HPA (hypothalamic-pituitary-adrenal) axis into a state of sustained activation. This produces elevated cortisol, disrupted circadian cortisol rhythm, and eventual adrenal fatigue. Elevated cortisol suppresses sex hormone production and disrupts thyroid function. The dysphoria and anxiety that characterize stimulant withdrawal and post-acute recovery are partly driven by cortisol dysregulation that persists for weeks to months after the last use.
Benzodiazepines — Thyroid Suppression and HPA Blunting. Chronic benzodiazepine use blunts HPA axis reactivity and suppresses TRH-induced TSH release, which can depress thyroid function. Growth hormone secretion, which is closely tied to sleep architecture, is also disrupted. The prolonged cognitive impairment that characterizes benzo withdrawal and PAWS has, in part, an endocrine component that standard detox protocols do not assess.
Why This Matters for Recovery — Not Just Detox
Hormonal imbalance is one of the most underrecognized drivers of post-acute withdrawal syndrome (PAWS) and early relapse. Consider what OPIAD produces in a male opioid patient who has just completed detox: fatigue, depression, anhedonia, low libido, poor sleep, and reduced motivation. These are identical to the symptoms of hypogonadism — because that is what OPIAD is. If that patient’s testosterone is not tested and the deficiency not identified, he will likely be told his symptoms are psychological or just PAWS, and sent home with a therapy referral. His hormonal deficiency will go untreated for months, and the sustained dysphoria drives relapse.
The same logic applies to women with alcohol-related progesterone disruption experiencing mood instability and sleep disruption, or stimulant patients with cortisol dysregulation experiencing anxiety and cravings weeks after detox. If the hormonal component is not measured, it cannot be addressed. At Pathways, we measure it.
What Pathways Tests: Comprehensive Blood Panel on Admission
Every patient admitted to Pathways receives a comprehensive blood panel. The hormone-relevant markers we assess include:
- Total testosterone and free testosterone (men)
- Estradiol and progesterone (women; and estradiol in men where clinical picture warrants)
- LH (luteinizing hormone) and FSH (follicle-stimulating hormone)
- Cortisol (AM draw, for proper circadian reference)
- TSH (thyroid-stimulating hormone) with reflex to Free T3/T4 where indicated
- Complete metabolic panel (liver function, electrolytes — directly affected by alcohol use)
- CBC (complete blood count)
- Vitamin D (25-OH) — severely depleted in most substance users and directly linked to mood and immune function
Results are reviewed by our physician. Patients receive a summary of findings relevant to their care. Where results indicate clinically significant hormonal deficiency, the physician discusses options with the patient — including referral to endocrinology or primary care post-discharge with lab results in hand.
HRT Integration During and After Detox
Pathways is not a hormone replacement clinic. We are a medically supervised detox facility that treats the whole patient — including what substances have done to their endocrine system. HRT integration at Pathways means:
For patients already on HRT: Continuity of care. If you arrive on testosterone replacement therapy, estrogen therapy, or any other hormone protocol, you will not be asked to stop during your detox stay. We continue clinically appropriate hormone therapy and document it as part of your medication record.
For patients with confirmed hormonal deficiency on admission labs: Our physician discusses the findings and, where appropriate, may initiate hormone support during the stay or provide a documented referral for immediate follow-up with endocrinology or primary care post-discharge. We do not leave patients with a lab result that says their testosterone is 85 ng/dL and send them home without a plan.
For all patients: Your admission labs travel with you in your discharge documentation. You have a hormonal baseline established at the point of detox — a clinical starting point that your post-discharge providers can use to track recovery and guide further treatment decisions.
Who This Benefits Most
- Men who have been on opioids or methadone for 2 or more years — OPIAD is common and measurable in this population
- Women in perimenopause or menopause who drink heavily — alcohol accelerates hormonal disruption in this group
- Anyone who has completed previous treatment episodes and relapsed in the weeks following detox despite apparent commitment to recovery
- Patients reporting severe fatigue, depression, or libido loss during prior recovery attempts that resolved with relapse
- Anyone currently on TRT, estrogen therapy, or other HRT who is concerned about interruption during treatment
- Stimulant users experiencing prolonged anxiety, mood instability, or cognitive fog beyond the expected withdrawal window
The Connection Between Hormones and Cravings
Low testosterone is directly associated with anhedonia — the inability to feel pleasure — through its interaction with dopamine signaling in the reward pathway. In a recovering opioid patient with OPIAD, the dopamine system is already depleted from years of exogenous opioid use. Layer on clinically low testosterone and you have a patient who literally cannot feel normal pleasure from daily life. The pull back toward substance use — which provides an immediate, if temporary, dopamine response — becomes neurobiologically compelling. Treating the hormonal component does not eliminate craving, but it removes one of the most powerful drivers of early-recovery misery that standard detox protocols leave unaddressed.
Cortisol dysregulation in stimulant recovery produces a different but equally powerful craving pattern: anxiety-driven use. Elevated cortisol without adequate buffering by sex hormones and normal HPA regulation creates a sustained state of physiological stress. Substances that temporarily dampen this state become attractive. Again — measurable, addressable, and currently invisible to most detox programs.
Frequently Asked Questions
Can low testosterone make addiction recovery harder?
Yes — and the mechanism is direct. Testosterone interacts with the dopamine system, which governs motivation, reward, and pleasure. Men with low testosterone (hypogonadism) experience anhedonia, fatigue, low motivation, and depression — symptoms that are identical to PAWS and that make early recovery miserable. In opioid-dependent men, OPIAD (opioid-induced androgen deficiency) can produce testosterone levels below 200 ng/dL. If that deficiency is not identified and addressed, the patient experiences prolonged dysphoria that is a primary driver of early relapse. Testing and treating low testosterone in men in opioid recovery is supported by clinical literature and makes both physiological and practical sense.
Will Pathways check my hormone levels when I’m admitted?
Yes. Every patient at Pathways receives a comprehensive blood panel on admission that includes testosterone (men), estradiol and progesterone (women), LH, FSH, cortisol, TSH, complete metabolic panel, CBC, and vitamin D. Results are reviewed by our physician and discussed with you as part of your care. This is standard at Pathways — not an add-on or an upcharge. You will leave with a documented hormonal baseline regardless of what your results show.
Can I continue my testosterone or HRT while in detox at Pathways?
Yes. If you are currently on testosterone replacement therapy, estrogen therapy, progesterone, thyroid hormone, or any other prescribed hormone protocol, you will continue that therapy during your stay at Pathways. We do not interrupt clinically prescribed hormone therapy as part of detox admission. Bring your current prescriptions and documentation from your prescribing provider when you arrive — our physician will review and continue your protocol as part of your admission medication reconciliation.
Does alcohol cause hormonal problems in men?
Yes — directly and measurably. Alcohol impairs hepatic estrogen metabolism, causing estrogen levels to rise in men. Elevated estrogen suppresses testosterone production via negative feedback on the HPG axis. Chronic heavy drinkers often have elevated estradiol, reduced testosterone, and in some cases gynecomastia (breast tissue development). These changes are reversible with abstinence — but the timeline varies and depends on the severity and duration of use. Blood panel findings at admission give us a baseline; post-discharge labs can track recovery of hormonal function over time.
Is hormonal imbalance why I feel depressed months after getting clean?
It may be a significant contributing factor — especially in men who used opioids long-term, women with heavy alcohol use history, and stimulant users. The symptoms of hormonal deficiency (fatigue, low mood, anhedonia, poor sleep, reduced motivation) are clinically indistinguishable from PAWS when viewed in isolation. Standard PAWS management does not include hormonal assessment. If you have completed detox and are doing everything right but still feel profoundly depressed or flat for months, asking your doctor to run a hormone panel is clinically reasonable. At Pathways, we run that panel at admission — so by the time you leave, you already have the answer.
Do you offer testosterone replacement therapy at your facility?
We do not operate a standalone TRT clinic. What we do is identify hormonal deficiency through comprehensive admission labs, discuss findings with patients, continue existing hormone therapy protocols for patients already on TRT or HRT, and provide documented lab results and clinical context for post-discharge follow-up with endocrinology or primary care. Where clinical presentation and lab results together support initiating hormone therapy during a patient’s stay, our physician may do so — but this is individualized and physician-directed, not a program feature offered to all patients. The goal is accurate diagnosis and appropriate referral, not routine TRT prescribing in a detox context.
Pathways Recovery Center is available 24 hours a day. Call (866) 708-2115 for a free assessment and same-day insurance verification. Admission can often be arranged the same day you call.
